Cannabis Bioscience International Holdings Inc.(CBIH)
USD --+0.00%
Reward47Moderate
Risk82High
📊75%Data
Revenue down 25% YoY
CBIH
+0.0 · +0.00%
USD · PINK
Cannabis Bioscience International Holdings Inc. | Healthcare
Speculative Momentum
Market Cap:4.65M
ℹ️
Reward Rating
47
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
82
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CBIH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Cannabis Bioscience International Holdings Inc.?

engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally.

CBIH · Verdict

Moderate reward · high risk

CBIH has limited near-term tailwinds — balance sheet and cash flow weigh on the model output.

Based on 88% data coverage

CBIH · Verdict

What’s working & what to watch

Watchouts 4

  • Balance sheet14/100

    Current ratio 0.03

  • Cash flow20/100

    -109% free-cash-flow margin

  • Volatility20/100

    Weak vs peers

  • Profitability35/100

    -181% net margin · 0% ROE

Model-based scoring. For information only — not financial advice.

What is Cannabis Bioscience International Holdings Inc.?

engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 4.65M.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (47)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap4.65M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0008
52 Week Low0.0003
Last AnnualMay
IPO DateN/A
IncorporatedUSA
Shares Outstanding12B
No. of Employees2
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta1.882
CurrencyUSD